Recent Finacing
Recent Raise
Achilles Therapeutics develops personalized T-cell therapies for solid tumors by identifying patient-specific clonal neoantigens via its PELEUS bioinformatics platform and manufacturing autologous T-cell products, in melanoma and NSCLC trials.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
